British Heart Foundation to Provide $1.7M for Genetic Screening of Familial Hypercholesterolaemia | GenomeWeb

NEW YORK (GenomeWeb) – The British Heart Foundation said today it is funding more than £1 million ($1.7 million) to a genetic testing program for familial hypercholesterolaemia, a condition that can shorten a patient's life by 20 to 30 years if left untreated.

The program being funded by BHF will pay for nurses to screen patients and their family members for the condition. It also will go toward extending such screening services to eight NHS Trusts across England and Scotland, BHF said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.